Company Filing History:
Years Active: 2024
Title: Christian Buchholz: Innovator in Targeted T Cell Transduction
Introduction
Christian Buchholz is a notable inventor based in Bergisch Gladbach, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies for T cell subsets. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Christian Buchholz holds a patent for a "CD62L specific lentiviral vector particle for targeted transduction of T cell subsets." This invention provides a composition that includes a pseudotyped retroviral vector particle. The vector comprises an envelope protein with antigen-binding activity, which is a recombinant protein that does not interact with at least one of its original receptors. This innovative approach aims to enhance the specificity and efficacy of T cell therapies.
Career Highlights
Christian is currently employed at Miltenyi Biorec B.V. Co., Kg, where she continues to push the boundaries of research in cellular therapies. Her work is characterized by a commitment to improving therapeutic outcomes for patients through innovative biotechnological solutions.
Collaborations
Christian collaborates with esteemed colleagues such as Thomas Schaser and Andrew Kaiser, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Christian Buchholz exemplifies the spirit of innovation in biotechnology through her groundbreaking patent and ongoing work at Miltenyi Biorec. Her contributions are paving the way for advancements in targeted T cell therapies, showcasing the impact of dedicated inventors in the medical field.